Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Immunodeficiency”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Large-scale testing (Phase 3)Study completedNCT02817451
What this trial is testing

DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 53
Not applicableStudy completedNCT00341705
What this trial is testing

The Second Multicenter Hemophilia Cohort Study

Who this might be right for
Liver DecompensationHepatocellular CarcinomaNon-Hodgkin Lymphoma
National Cancer Institute (NCI) 2,565
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Not applicableUnknownNCT03705611
What this trial is testing

Secondary Distribution of HIV Self-tests Through Antenatal Care Clinic Attendees and Index Clients

Who this might be right for
HIV/AIDSHIV Infections
London School of Hygiene and Tropical Medicine 10,000
Not applicableStudy completedNCT03054181
What this trial is testing

Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)

Who this might be right for
Primary ImmunodeficiencySecondary Immune Deficiency
GWT-TUD GmbH 156
Not applicableStudy completedNCT00886990
What this trial is testing

Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Who this might be right for
HIV InfectionHIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 240
Not applicableLooking for participantsNCT06659588
What this trial is testing

Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency

Who this might be right for
Humoral Primary Immunodeficiencies (PIDs)Secondary Form of Humoral ImmunodeficienciesCombined Immunodeficiency (CID)+1 more
Assistance Publique - Hôpitaux de Paris 120
Large-scale testing (Phase 3)Study completedNCT02259127
What this trial is testing

ODYSSEY (PENTA 20)

Who this might be right for
HIV Infection
PENTA Foundation 792
Not applicableStudy completedNCT05074251
What this trial is testing

Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV

Who this might be right for
HIV InfectionsARTHIV Seropositivity
University of California, Los Angeles 180
Not applicableStudy completedNCT03135067
What this trial is testing

Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk

Who this might be right for
Human Immunodeficiency Virus
University of Pennsylvania 2,102
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Large-scale testing (Phase 3)UnknownNCT03988452
What this trial is testing

Nucleosides And Darunavir/Dolutegravir In Africa

Who this might be right for
Human Immunodeficiency Virus
Makerere University 465
Not applicableStudy completedNCT00517803
What this trial is testing

Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies

Who this might be right for
HIV InfectionsCancer, Second Primary
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 24
Not applicableLooking for participantsNCT01666080
What this trial is testing

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Who this might be right for
Hematologic DisordersHemoglobinopathiesImmunodeficiencies
Masonic Cancer Center, University of Minnesota 30
Not applicableLooking for participantsNCT05879757
What this trial is testing

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

Who this might be right for
Multiple MyelomaSecondary Immunodeficiency (SID)
Takeda 75
Large-scale testing (Phase 3)Study completedNCT03211065
What this trial is testing

Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig

Who this might be right for
Secondary Immune Deficiency
Rochester General Hospital 16
Not applicableActive Not RecruitingNCT04354129
What this trial is testing

Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

Who this might be right for
Primary Immune Deficiency DisorderSecondary Immune Deficiency
University of Alberta 36
Not applicableStudy completedNCT01118767
What this trial is testing

Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru

Who this might be right for
HIVAdherenceSexual Behavior+1 more
Universidad Peruana Cayetano Heredia 210
Testing effectiveness (Phase 2)WithdrawnNCT00008866
What this trial is testing

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Load More Results